Evidence that the atypical 5‐HT<sub>3</sub> receptor ligand, [<sup>3</sup>H]‐BRL46470, labels additional 5‐HT<sub>3</sub> binding sites compared to [<sup>3</sup>H]‐granisetron

Lucinda J. Steward(University of Birmingham), Thomas P. Blackburn(New Frontier), P.C. Barber(University of Birmingham), Kim R Bentley(University of Birmingham), John A. Peters(University of Dundee), Jeremy J. Lambert(Ninewells Hospital), Jian Ge(Anhui Medical University), Anthony G. Hope(Ninewells Hospital)
British Journal of Pharmacology
September 1, 1995
Cited by 30


Related Papers

Neurosteroids and GABAA receptor function
|Trends in Pharmacological Sciences|1995|743
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
|British Journal of Pharmacology|2017|597